Intrathecal infusion therapy with dexmedetomidine-supplemented morphine in cancer pain

Yükleniyor...
Küçük Resim

Tarih

2007

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Blackwell Publishing

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Sir, Pain is one of the most important symptoms of end-stage cancer that needs to be controlled. Dexmedetomidine is an alpha2 agonist with sedative and analgesic properties (1). Intrathecal dexmedetomidine for the relief of cancer pain has not been reported in the literature previously. In this communication, the use of intrathecal dexmedetomidine-supplemented morphine is reported in a patient with cancer.

Açıklama

Anahtar Kelimeler

Cancer Pain

Kaynak

Acta Anaesthesiologica Scandinavica

WoS Q Değeri

Q2

Scopus Q Değeri

Q1

Cilt

51

Sayı

3

Künye